Management of ER positive metastatic breast cancer von McAndrew, Nicholas P., Finn, Richard S.

Volltext

Advances in Targeted Therapies for Triple-Negative Breast Cancer von McCann, Kelly E., Hurvitz, Sara A., McAndrew, Nicholas

Volltext

Clinical Review on the Management of Hormone Receptor-Positive Metastatic Breast Cancer von McAndrew, Nicholas P, Finn, Richard S

Volltext

Preclinical and clinical activity of DZD1516, a full blood-brain barrier-penetrant, highly selective HER2 inhibitor von Zhang, Jian, McAndrew, Nicholas P, Wang, Xiaojia, Du, Yiqun, DiCarlo, Brian, Wang, Mei, Chen, Kan, Yu, Wenlei, Hu, Xichun

Volltext

Early treatment-related neutropenia predicts response to palbociclib von McAndrew, Nicholas P., Dickson, Mark A., Clark, Amy S., Troxel, Andrea B., O’Hara, Mark H., Colameco, Christopher, Gallager, Maryann, Gramlich, Kristi, Zafman, Kelly, Vaughn, David, Schwartz, Gary K., O’Dwyer, Peter J., DeMichele, Angela

Volltext

Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer von Clark, Amy S, McAndrew, Nicholas P, Troxel, Andrea, Feldman, Michael, Lal, Priti, Rosen, Mark, Burrell, Jessica, Redlinger, Colleen, Gallagher, Maryann, Bradbury, Angela R, Domchek, Susan M, Fox, Kevin R, O'Dwyer, Peter J, DeMichele, Angela M

Volltext

A careful reassessment of anthracycline use in curable breast cancer von Hurvitz, Sara Alsterlind, McAndrew, Nicholas P., Bardia, Aditya, Press, Michael F., Pegram, Mark, Crown, John P., Fasching, Peter A., Ejlertsen, Bent, Yang, Eric H., Glaspy, John A., Slamon, Dennis J.

Volltext

Chemotherapy regimen choice and patient outcomes in early-stage triple-negative breast cancer: a retrospective analysis von Ghafouri, Sanaz N., Nayeri, Rebecca W., McAndrew, Nicholas P., Hurvitz, Sara A.

Volltext

Surgical outcomes following neoadjuvant chemotherapy with and without immunotherapy in patients with triple-negative breast cancer von Holt, Anouchka Coste, Smith, Courtney A., Berkowitz, Maurice J., Baker, Jennifer L., McAndrew, Nicholas P., Kapoor, Nimmi S.

Volltext

Effects of systemic inflammation on relapse in early breast cancer von McAndrew, Nicholas P., Bottalico, Lisa, Mesaros, Clementina, Blair, Ian A., Tsao, Patricia Y., Rosado, Jennifer M., Ganguly, Tapan, Song, Sarah J., Gimotty, Phyllis A., Mao, Jun J., DeMichele, Angela

Volltext

Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer von Makhlin, Igor, McAndrew, Nicholas P., Wileyto, E. Paul, Clark, Amy S., Holmes, Robin, Bottalico, Lisa N., Mesaros, Clementina, Blair, Ian A., Jeschke, Grace R., Fox, Kevin R., Domchek, Susan M., Matro, Jennifer M., Bradbury, Angela R., Feldman, Michael D., Hexner, Elizabeth O., Bromberg, Jacqueline F., DeMichele, Angela

Volltext

Early clinical safety and pharmacokinetics data of DZD1516, an BBB-penetrant selective HER2 inhibitor for the treatment of HER2-positive metastatic breast cancer von Hu, Xichun, Zhang, Jian, McAndrew, Nicholas Patrick

Volltext

UCLA B-13: A phase 1b trial evaluating the safety of ribociclib, tucatinib, and trastuzumab in patients with metastatic, HER2+ breast cancer and a multicenter, randomized, open-lab... von McAndrew, Nicholas Patrick, Hurvitz, Sara A., Tetef, Merry L., Kivork, Christine, Ikenouye, Larissa, Slamon, Dennis J.

Volltext

Abstract P2-13-43: Preclinical and early clinical safety and pharmacokinetics data of DZD1516, an BBB-penetrant selective HER2 inhibitor for the treatment of HER2 positive metastat... von Zhang, Jian, McAndrew, Nicholas, Yu, Wenlei, Pan, Xiaomei, Wang, Mei, Hu, Xichun

Volltext

Ribociclib plus Endocrine Therapy in Early Breast Cancer von Slamon, Dennis, Lipatov, Oleg, Nowecki, Zbigniew, McAndrew, Nicholas, Kukielka-Budny, Bozena, Stroyakovskiy, Daniil, Yardley, Denise A., Huang, Chiun-Sheng, Fasching, Peter A., Crown, John, Bardia, Aditya, Chia, Stephen, Im, Seock-Ah, Ruiz-Borrego, Manuel, Loi, Sherene, Xu, Binghe, Hurvitz, Sara, Barrios, Carlos, Untch, Michael, Moroose, Rebecca, Visco, Frances, Afenjar, Karen, Fresco, Rodrigo, Severin, Irene, Ji, Yan, Ghaznawi, Farhat, Li, Zheng, Zarate, Juan P., Chakravartty, Arunava, Taran, Tetiana, Hortobagyi, Gabriel

Volltext

Chemotherapy-related outcomes in triple-negative breast cancer von Wellmann, Rebecca M., Ghafouri, Sanaz N., McAndrew, Nicholas Patrick, Hurvitz, Sara A.

Volltext

Challenges in the clinical utility of the serum test for HER2 ECD von Lam, Lian, McAndrew, Nicholas, Yee, Marla, Fu, Ting, Tchou, Julia C., Zhang, Hongtao

Volltext

Abstract LB052: Cell cycle synchronization: Biomarker analysis in a phase I trial of alternating ribociclib and paclitaxel in advanced breast cancer von Clark, Amy, Elmi, Azadeh, McAndrew, Nicholas P., Wileyto, Paul, Shih, Natalie, Feldman, Michael, Rosen, Mark, Savage, Jessica, Holmes, Robin, Dinubile, Nancy, Berger, Theresa, Schubert, Erin, Matthai, Alice, Volpe, Melissa, Shah, Payal, Domchek, Susan, Mankoff, David, DeMichele, Angela

Volltext

TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer von Hurvitz, Sara A., Peddi, Parvin F., Tetef, Merry L., McAndrew, Nicholas Patrick, Master, Aashini K., DiNome, Maggie L., Lee, Minna K, Wang, Lisa S., Spring, Laura, Kivork, Christine, Chauv, James, Bardia, Aditya

Volltext

TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early-stage breast cancer von Hurvitz, Sara A., Wang, Lisa S., Chan, David, Phan, Vu, Lomis, Thomas, McAndrew, Nicholas Patrick, Spring, Laura, Tetef, Merry L., Villa, Deborah, Applebaum, Steven, Chamberlain, Erin, Dakhil, Shaker R., DiCarlo, Brian Anthony, Kim, David D., Kirimis, Evangelia K., Lawler, William E., Master, Aashini K., Kivork, Christine, Chauv, James, Bardia, Aditya

Volltext